Joel Greenblatt's BHC Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 57,161 shares of Bausch Health Companies Inc. (BHC) worth $397,269, representing 0.00% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 36 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in BHC, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2017, adding 823,046 shares. Largest reduction occurred in Q4 2017, reducing 442,596 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Bausch Health Companies (BHC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bausch Health Companies (BHC) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +137 | Add 0.24% | 57,161 | $6.95 |
| Q3 2025 | -18,434 | Reduce 24.43% | 57,024 | $6.45 |
| Q2 2025 | -26,984 | Reduce 26.34% | 75,458 | $6.66 |
| Q1 2025 | +36,290 | Add 54.86% | 102,442 | $6.47 |
| Q4 2024 | +66,152 | New Buy | 66,152 | $8.06 |
| Q2 2023 | -44,247 | Sold Out | 0 | $0.00 |
| Q1 2023 | -29,331 | Reduce 39.86% | 44,247 | $8.10 |
| Q4 2022 | -20,216 | Reduce 21.55% | 73,578 | $6.28 |
| Q3 2022 | -7,100 | Reduce 7.04% | 93,794 | $6.89 |
| Q2 2022 | +82,735 | Add 455.61% | 100,894 | $8.36 |
| Q1 2022 | +6,915 | Add 61.50% | 18,159 | $22.85 |
| Q4 2021 | +11,244 | New Buy | 11,244 | $27.57 |
| Q2 2021 | -21,108 | Sold Out | 0 | $0.00 |
| Q1 2021 | +21,108 | New Buy | 21,108 | $31.74 |
| Q3 2020 | -11,511 | Sold Out | 0 | $0.00 |
| Q2 2020 | +11,511 | New Buy | 11,511 | $18.33 |
| Q1 2020 | -114,815 | Sold Out | 0 | $0.00 |
| Q4 2019 | -83,888 | Reduce 42.22% | 114,815 | $29.92 |
| Q3 2019 | -33,075 | Reduce 14.27% | 198,703 | $21.85 |
| Q2 2019 | +231,778 | New Buy | 231,778 | $25.22 |
| Q4 2018 | -7,956 | Sold Out | 0 | $0.00 |
| Q3 2018 | +7,956 | New Buy | 7,956 | $25.64 |
| Q2 2018 | -32,408 | Sold Out | 0 | $0.00 |
| Q1 2018 | +2 | Add 0.01% | 32,408 | $15.92 |
| Q4 2017 | -442,596 | Reduce 93.18% | 32,406 | $20.77 |
| Q3 2017 | -348,044 | Reduce 42.29% | 475,002 | $14.33 |
| Q2 2017 | +823,046 | New Buy | 823,046 | $17.30 |
| Q2 2016 | -15,088 | Sold Out | 0 | $0.00 |
| Q1 2016 | +15,088 | New Buy | 15,088 | $26.31 |
| Q4 2015 | -88,677 | Sold Out | 0 | $0.00 |
| Q3 2015 | +27,499 | Add 44.95% | 88,677 | $178.38 |
| Q2 2015 | -4,353 | Reduce 6.64% | 61,178 | $222.16 |
| Q1 2015 | -230,101 | Reduce 77.83% | 65,531 | $198.62 |
| Q4 2014 | +295,632 | New Buy | 295,632 | $143.11 |
| Q3 2014 | -6,172 | Sold Out | 0 | $0.00 |
| Q2 2014 | +6,172 | New Buy | 6,172 | $126.05 |
Joel Greenblatt's Bausch Health Companies Investment FAQs
Joel Greenblatt first purchased Bausch Health Companies Inc. (BHC) in Q2 2014, acquiring 6,172 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Bausch Health Companies Inc. (BHC) for 36 quarters since Q2 2014.
Joel Greenblatt's largest addition to Bausch Health Companies Inc. (BHC) was in Q2 2017, adding 823,046 shares worth $14.24 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 57,161 shares of Bausch Health Companies Inc. (BHC), valued at approximately $397,269.
As of the Q4 2025 filing, Bausch Health Companies Inc. (BHC) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Bausch Health Companies Inc. (BHC) was 823,046 shares, as reported at the end of Q2 2017.